Form 4: UL Solutions Director Accrues Dividend Rights

Sentiment:

Insider Transaction Report


UL Solutions Inc. Director Michael H. Thaman reported the accrual of 4 dividend equivalent rights on restricted stock units, increasing his beneficial ownership to 2,801 derivative securities.

Summary

  • Michael H. Thaman, a Director of UL Solutions Inc. (ULS), reported the accrual of 4 dividend equivalent rights.
  • These rights are associated with restricted stock units (RSUs) he holds.
  • Each dividend equivalent right represents a contingent right to receive one share of UL Solutions Inc.'s Class A Common Stock.
  • The dividend equivalent rights vest proportionately with the underlying restricted stock units.
  • The restricted stock units are scheduled to vest on the earlier of May 20, 2026, or the date of the annual meeting following their grant date.
  • Following this transaction, Mr. Thaman beneficially owns a total of 2,801 derivative securities, which include both restricted stock units and all accrued dividend equivalent rights.
  • The transaction was made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 6

Explanation: Neutral to slightly positive. The accrual of dividend equivalent rights is a routine compensation event for a director, indicating continued alignment of interests. It's not a significant market-moving event but reflects ongoing equity participation.

Positives

  • Director Michael H. Thaman's beneficial ownership of derivative securities increased by 4 dividend equivalent rights, aligning his interests further with shareholders.
  • The transaction was executed under a Rule 10b5-1(c) plan, indicating a pre-planned and systematic approach to equity compensation.

Future Outlook

The vesting of the restricted stock units and associated dividend equivalent rights is contingent on future dates, specifically the earlier of May 20, 2026, or the date of the annual meeting following the grant date.

Industry Context

This filing is a routine disclosure of insider equity compensation, common across all industries for publicly traded companies. It reflects standard practices for aligning executive and director interests with shareholder value through equity awards.

Stakeholder Impact

  • Shareholders: The accrual of dividend equivalent rights for a director further aligns management's interests with shareholder value, as the director's compensation is tied to the company's stock performance.

Next Steps

  • The restricted stock units and associated dividend equivalent rights will vest on the earlier of May 20, 2026, or the date of the annual meeting following the grant date.

Key Dates

DateDescription
12/08/2025Date of earliest transaction, representing the accrual of dividend equivalent rights.
12/10/2025Date the Form 4 was signed by the Attorney-in-Fact.
05/20/2026Earliest potential vesting date for the restricted stock units and associated dividend equivalent rights.

Recommendation

hold

This Form 4 filing details a routine accrual of dividend equivalent rights for a director as part of their compensation, executed under a 10b5-1 plan. It represents a minor increase in beneficial ownership and is not indicative of any significant operational or financial changes that would warrant a change in investment recommendation. The transaction itself is neutral, reinforcing the director's alignment with shareholder interests but not providing new information to alter the fundamental investment thesis for UL Solutions Inc.

Keywords

UL Solutions, ULS, Form 4, Insider Trading, Beneficial Ownership, Restricted Stock Units, Dividend Equivalent Rights, Director Compensation, Michael H. Thaman, Equity Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.